Immunotherapy for Small Cell Lung Cancer: Established Applications and Novel Approaches

Abstract: Small cell lung cancer (SCLC) is a devastating disease that has a case fatality rate of more than 90% despite best available treatments. As a […]

Hem/Onc News

Pembrolizumab Receives Regular Approval in Metastatic Nonsquamous NSCLC On August 20, the US Food and Drug Administration (FDA) granted regular approval to pembrolizumab (Keytruda, Merck) for […]

Looking Ahead to New Therapies in Small Cell Lung Cancer

H&O How common is small cell lung cancer (SCLC)? CR Approximately 25,000 to 30,000 cases of SCLC occur each year in the United States, a number […]